The ESETT Trial: 2nd Line Medications in Status Epilepticus
December 23, 2019
Background: Dealing with a patient in status epilepticus, refractory to treatment with benzodiazepines, can be a sphincter tightening ordeal. While most seizure activity responds to...
Marco Torres